U.S. Physical Therapy appoints Myra Davis: analysts target U.S. Physical Therapy stock at USD 98.25

Published on 10/07/2026 at 02:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Consensus target is USD 98.25 against a USD 83.76 quote. U.S. Physical Therapy stock last closed at EUR 74.25 on October 5, 2026.

USPH, US90337L1089, Illustration mit AI erstellt.

U.S. Physical Therapy (USPH) appointed Myra Davis to its board effective October 1, 2026, while a seven-analyst consensus target stands at USD 98.25. Business Wire reported the appointment on September 21, 2026, and MarketBeat lists the target on its October 6, 2026 stock page.

Technology expertise joins the board

Davis is executive vice president and chief information innovation officer at Texas Children's Hospital, where she has held information technology roles since 2003. She also serves on the board of Werfen, giving USPH an incoming director with healthcare technology and governance experience.

The appointment adds a digital operating perspective to a company that owns or manages 799 outpatient physical therapy clinics in 45 states, according to the September 21, 2026 release from Business Wire.

Revenue grows as profit pressure persists

USPH generated USD 214.1 million of revenue in the second quarter of 2026, up 8.50 percent from the second quarter of 2025. The company also reaffirmed adjusted earnings before interest, taxes, depreciation and amortization guidance of USD 102 million to USD 106 million for full-year 2026, according to Yahoo Finance.

The comparison is less favorable below revenue: second-quarter net income attributable to USPH shareholders fell to USD 9.9 million from USD 12.4 million a year earlier, while earnings per share declined to USD 0.25 from USD 0.58. Cash stood at USD 24.9 million on June 30, 2026, down from USD 35.6 million at the end of 2025, while credit-facility borrowings rose to USD 221.0 million from USD 161.8 million.

Target sits above the market quote

MarketBeat's USD 98.25 consensus target is based on seven analysts and compares with its USD 83.76 quote, implying 17.30 percent upside on that source's dollar basis. The target is therefore separate from the euro reference price used for German-market readers.

The NYSE quote was last at USD 83.63 on October 6, 2026. The same market context places USPH's market capitalization at USD 1.3 billion and its 52-week range at USD 58.19 to USD 93.50.

Prior close sets the euro reference

The Lang & Schwarz prior close was EUR 74.25 on October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of U.S. Physical Therapy stock.